Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

dual drug MNP-encapsulated PLGA NP

Based on

1 Articles
2014 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role raw materials
2

(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione

1,7-bis(4-hydroxy-3-methoxy phenyl)-1,6-heptadiene-3,5-diene 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione keto form curcumin diferuloylmethane curcumin CCM CUM CUR Cum Cur CM CU Cm
Type Single Compound
Formula C21H20O6
Role raw materials
3

5-fluoro-2,4(1H,3H)pyrimidinedione

5-Fluorouracil 5-fluorouracil fluorouracil Adrucil® Efudex® adrucil efudex 5-FU 5-Fu 5FU
Type Single Compound
Formula C4H3FN2O2
Role raw materials
4

superparamagnetic iron oxide nanoparticles

SPION MNP
Type Nano Material
Formula
Role raw materials

Properties

Applications

Characterization

Method Source
X-ray photoelectron spectroscopy

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
human breast cancer cell line MCF7

1 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 5-fluoro-2,4(1H,3H)pyrimidinedione
  • poly(lactic-co-glycolic acid)
  • (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
See all (4)
  1. AfbvCGUJkeI4u
Product

dual drug MNP-encapsulated PLGA NP

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial